# The new frontier in assisted reproduction: Consumer Desire vs. Regulatory and Ethical Precaution in AI-assisted Polygenic Embryo Screening

## TL;DR

AI-assisted polygenic embryo screening in IVF raises ethical and regulatory questions across different national contexts.

## Contribution

The paper introduces AI-assisted polygenic embryo screening and analyzes its ethical implications in three distinct national frameworks.

## Key findings

- AI-assisted screening can predict implantation success and disease risks in embryos.
- Germany, Israel, and the US show contrasting regulatory and ethical responses to the technology.
- Consumer desire for the technology conflicts with legal and ethical caution in some regions.

## Abstract

AI-assisted polygenic embryo screening is a new technology to predict embryonic implantation, disease risk and non-clinical traits for IVF embryos. To highlight its social and ethical implications, we locate it within the national landscapes of Germany’s legal caution, Israel’s techno-enthusiasm and US market liberalism.